Radiation Shielding Analysis of Niowave’s Uranium Target Assembly 2 (UTA-2) Facility for Molybdenum-99 Production
Niowave is seeking to develop a commercial medical isotope production process using a low-enriched uranium accelerator-driven subcritical reactor (ADSR) system to produce molybdenum-99. As part of the US Department of Energy national laboratory support to develop low enriched uranium molybdenum-99 production technologies, Oak Ridge National Laboratory is providing research and development resources to assist Niowave in the design and licensing process of its technology. The goals of this work under the radiation shielding task are to assist Niowave in developing a methodology and framework for efficient radiation shielding simulations of their Uranium Target Assembly 2 facility and to provide preliminary radiation shielding calculations and design recommendations for the facility.